Article
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins
26 Jan 2022
Abstract excerpt
T-cell acute lymphoblastic leukemias (T-ALL) represent 15% of pediatric and 25% of adult ALL. Since they have a particularly poor outcome in relapsed/refractory cases, identifying prognosis factors at diagnosis is crucial to adapting treatment for high-risk patients. Unlike acute myeloid leukemia and BCP ALL, chromosomal rearrangements leading to chimeric fusion-proteins with strong prognosis impact are sparsely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
